RxDoctor Payments Data

Wendy Bond, MD

Neurology · Fort Myers, FLNPI 1295737906

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,750 of the $2,396 with a category attached, or 73.0%. Eli Lilly accounts for 78.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $1,910 and has fallen 98.8% since, to $24 in 2025. That places this record below the midpoint for neurology clinicians in FL, where the typical reported total is $1,698.

$2,396in general payments, 2019–2025

Across 11 payments — averaging $217.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • Eisai Inc.$483
  • Otsuka America Pharmaceutical, Inc.$24
$14,726,766in research payments, 2019–2025

Across 480 payments — averaging $30,681 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$6.2M
  • Biogen$4.6M
  • Eisai Inc.$1.3M
  • Genentech, Inc.$981K
  • AbbVie$739K
  • UCB SA$492K
  • plus $395K from 5 others

What the payments were for

  • Consulting fees$1,75073%
  • Travel & lodging$2038%
  • Food & beverage$44218%

General payments by program year

19
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly2$1,889
Eisai Inc.8$483
Otsuka America Pharmaceutical, Inc.1$24

How this compares

$2,396 in reported general payments places this provider in the 50th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida

Medicare billing

Part B allowed, 2024
$9,406
Medicare patients
27
Services billed
54

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →